Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Conditions:   Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis Interventions:   Drug: Cladribine Subcutaneous Injection;   Drug: 0.9% Chloride Injection Sodium Sponsors:   Institute of Psychiatry and Neurology, Warsaw;   Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences;   Mossakowski Medical Research Centre Polish Academy of Sciences;   Poznan University of Medical Sciences;   Military Institute of Aviation  Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials